Dasatinib Pharmascience 50 mg filmom obložene tablete
| Name | Dasatinib Pharmascience 50 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-493672126 |
| Active Substance | dasatinib |
| Composition | jedna filmom obložena tableta sadrži 50 mg dasatiniba (bezvodni oblik) |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Pharmascience International Limited, Nicosia, Cipar |
| Marketing Authorisation Holder | Pharmascience International Limited, Lampousas, 1, Nicosia, Cipar |
| Marketing Authorisation Date | 13.05.2020 |
| MA Period of Validity | 13.05.2025 |
| Classification Number | UP/I-530-09/19-01/35 |
| Registration Number | 381-12-01/154-20-02 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01EA02 |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
